| scholarly article | Q13442814 |
| P50 | author | Andrew P Rice | Q55277928 |
| P2093 | author name string | Tzu-Ling Sung | |
| Karen Chiang | |||
| P2860 | cites work | Identification of multiple cyclin subunits of human P-TEFb | Q24317025 |
| Fast and effective prediction of microRNA/target duplexes | Q24537313 | ||
| Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA | Q24619630 | ||
| Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps | Q24645826 | ||
| The impact of microRNAs on protein output | Q24653549 | ||
| Most mammalian mRNAs are conserved targets of microRNAs | Q24655061 | ||
| A new paradigm in eukaryotic biology: HIV Tat and the control of transcriptional elongation | Q24804709 | ||
| The role of RNAi and microRNAs in animal virus replication and antiviral immunity | Q27490179 | ||
| Mammalian microRNAs predominantly act to decrease target mRNA levels | Q27860535 | ||
| Origins and Mechanisms of miRNAs and siRNAs | Q27860822 | ||
| Widespread changes in protein synthesis induced by microRNAs | Q27860886 | ||
| Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs | Q27861053 | ||
| Regulation of TAK/P-TEFb in CD4+ T lymphocytes and macrophages | Q28253165 | ||
| Controlling the elongation phase of transcription with P-TEFb | Q28255518 | ||
| Causes and consequences of microRNA dysregulation in cancer | Q28258994 | ||
| A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA | Q28263974 | ||
| Upregulation of cyclin T1/CDK9 complexes during T cell activation | Q28292597 | ||
| Regulation of mRNA translation and stability by microRNAs | Q29547304 | ||
| A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes | Q29616620 | ||
| MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb | Q29619411 | ||
| Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA | Q30878993 | ||
| Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity | Q33220546 | ||
| Cyclin T1-dependent genes in activated CD4 T and macrophage cell lines appear enriched in HIV-1 co-factors | Q33367106 | ||
| miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1 | Q33400321 | ||
| Post-transcriptional regulation of miR-27 in murine cytomegalovirus infection | Q33611580 | ||
| Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines | Q33786066 | ||
| Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4(+) T lymphocytes by combination of cytokines | Q33849629 | ||
| Limited redundancy in genes regulated by Cyclin T2 and Cyclin T1. | Q33972021 | ||
| Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation | Q34154374 | ||
| Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes | Q34695803 | ||
| Lost in translation: an assessment and perspective for computational microRNA target identification | Q35005629 | ||
| Mini ways to stop a virus: microRNAs and HIV-1 replication | Q35055688 | ||
| The Yin and Yang of P-TEFb regulation: implications for human immunodeficiency virus gene expression and global control of cell growth and differentiation | Q35072999 | ||
| MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. | Q35114604 | ||
| T cell receptor signaling: beyond complex complexes | Q35745872 | ||
| miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely | Q35758613 | ||
| Contributions to our understanding of T cell physiology through unveiling the T cell proteome | Q36815232 | ||
| Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1). | Q36954414 | ||
| MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals | Q37102282 | ||
| Muscle stem cell behavior is modified by microRNA-27 regulation of Pax3 expression. | Q37304065 | ||
| ST14 (suppression of tumorigenicity 14) gene is a target for miR-27b, and the inhibitory effect of ST14 on cell growth is independent of miR-27b regulation | Q37371739 | ||
| Cellular microRNA and P bodies modulate host-HIV-1 interactions | Q37391014 | ||
| Physiological and pathological roles for microRNAs in the immune system | Q37680666 | ||
| MicroRNA-27b contributes to lipopolysaccharide-mediated peroxisome proliferator-activated receptor gamma (PPARgamma) mRNA destabilization. | Q38346380 | ||
| A high throughput experimental approach to identify miRNA targets in human cells. | Q38350728 | ||
| Induction of the HIV-1 Tat co-factor cyclin T1 during monocyte differentiation is required for the regulated expression of a large portion of cellular mRNAs. | Q38518336 | ||
| Effects of prostratin on Cyclin T1/P-TEFb function and the gene expression profile in primary resting CD4+ T cells | Q38557763 | ||
| Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference | Q39684598 | ||
| Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay | Q39711736 | ||
| Suppression of microRNA-silencing pathway by HIV-1 during virus replication | Q40166750 | ||
| MicroRNA regulates the expression of human cytochrome P450 1B1. | Q40230494 | ||
| Specific inhibition of HIV-1 replication by short hairpin RNAs targeting human cyclin T1 without inducing apoptosis | Q40418026 | ||
| Cyclin T1 expression is regulated by multiple signaling pathways and mechanisms during activation of human peripheral blood lymphocytes | Q46792411 | ||
| Cyclin T1 but not cyclin T2a is induced by a post-transcriptional mechanism in PAMP-activated monocyte-derived macrophages | Q81579403 | ||
| microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma | Q84623574 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 3244-3252 | |
| P577 | publication date | 2011-12-28 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Regulation of cyclin T1 and HIV-1 Replication by microRNAs in resting CD4+ T lymphocytes | |
| P478 | volume | 86 |
| Q34426498 | A role for microRNA-155 modulation in the anti-HIV-1 effects of Toll-like receptor 3 stimulation in macrophages |
| Q63351215 | Activating Latent HIV by Inhibiting Bromodomain Proteins |
| Q28546918 | An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression |
| Q28607211 | Antiretroviral Therapy Fails to Restore Levels of HIV-1 Restriction miRNAs in PBMCs of HIV-1-infected MSM |
| Q52671487 | Are microRNAs Important Players in HIV-1 Infection? An Update. |
| Q28661342 | Arginine rich short linear motif of HIV-1 regulatory proteins inhibits dicer dependent RNA interference |
| Q34432844 | Argonaute CLIP-Seq reveals miRNA targetome diversity across tissue types |
| Q36332978 | Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein |
| Q64083383 | Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies |
| Q41926635 | Changes in the cellular microRNA profile by the intracellular expression of HIV-1 Tat regulator: A potential mechanism for resistance to apoptosis and impaired proliferation in HIV-1 infected CD4+ T cells |
| Q57492030 | Control of Immunoregulatory Molecules by miRNAs in T Cell Activation |
| Q59349707 | Crosstalk in competing endogenous RNA networks reveals new circular RNAs involved in the pathogenesis of early HIV infection |
| Q42052356 | Cyclin T1 and CDK9 T-loop phosphorylation are downregulated during establishment of HIV-1 latency in primary resting memory CD4+ T cells. |
| Q54216878 | Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation. |
| Q38995028 | Cyclin-dependent kinases as therapeutic targets for HIV-1 infection. |
| Q37127522 | Deployment of the human immunodeficiency virus type 1 protein arsenal: combating the host to enhance viral transcription and providing targets for therapeutic development |
| Q34194608 | Differential microRNA expression profile between stimulated PBMCs from HIV-1 infected elite controllers and viremic progressors |
| Q26781191 | Epigenetic control of HIV-1 post integration latency: implications for therapy |
| Q42705630 | First Evidence for the Disease-Stage, Cell-Type, and Virus Specificity of microRNAs during Human Immunodeficiency Virus Type-1 Infection |
| Q54214251 | HIV latency reversing agents act through Tat post translational modifications. |
| Q38375685 | HIV-1 Tat Primes and Activates Microglial NLRP3 Inflammasome-Mediated Neuroinflammation. |
| Q36976156 | HIV-1 transcription and latency: an update |
| Q38718353 | HTLV-1 Tax activates HIV-1 transcription in latency models |
| Q38711900 | High-throughput sequencing identifies HIV-1-replication- and latency-related miRNAs in CD4+ T cell lines |
| Q39173861 | Histone deacetylase inhibitors (HDACis) that release the positive transcription elongation factor b (P-TEFb) from its inhibitory complex also activate HIV transcription |
| Q36548179 | Host restriction factors in retroviral infection: promises in virus-host interaction |
| Q41274276 | Identification of novel CDK9 and Cyclin T1-associated protein complexes (CCAPs) whose siRNA depletion enhances HIV-1 Tat function |
| Q38475595 | Integrated miRNA and mRNA transcriptomes of porcine alveolar macrophages (PAM cells) identifies strain-specific miRNA molecular signatures associated with H-PRRSV and N-PRRSV infection. |
| Q26781552 | Interaction of drugs of abuse and microRNA with HIV: a brief review |
| Q92152935 | Interferon-Inducible MicroRNA miR-128 Modulates HIV-1 Replication by Targeting TNPO3 mRNA |
| Q92344530 | Interferon-inducible TRIM22 contributes to maintenance of HIV-1 proviral latency in T cell lines |
| Q38091888 | Lost in transcription: molecular mechanisms that control HIV latency |
| Q38212042 | Making a Short Story Long: Regulation of P-TEFb and HIV-1 Transcriptional Elongation in CD4+ T Lymphocytes and Macrophages. |
| Q28072142 | Mammalian microRNA: an important modulator of host-pathogen interactions in human viral infections |
| Q39252620 | MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFκB pathway |
| Q38989939 | MiR-506 inhibits PRRSV replication in MARC-145 cells via CD151. |
| Q37036716 | MicroRNA 181 suppresses porcine reproductive and respiratory syndrome virus (PRRSV) infection by targeting PRRSV receptor CD163. |
| Q49181119 | MicroRNA expression profiling of intestinal mucosa tissue predicts multiple crucial regulatory molecules and signaling pathways for gut barrier dysfunction of AIDS patients |
| Q34747583 | MicroRNA regulation and its effects on cellular transcriptome in human immunodeficiency virus-1 (HIV-1) infected individuals with distinct viral load and CD4 cell counts |
| Q27003271 | MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development |
| Q38563711 | MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIV. |
| Q38566841 | MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases |
| Q35662247 | MicroRNA-155 Reinforces HIV Latency. |
| Q36404157 | MicroRNA-mediated restriction of HIV-1 in resting CD4+ T cells and monocytes. |
| Q36435987 | MicroRNAs and HIV-1: complex interactions |
| Q40097287 | MicroRNAs as Important Players in Host-Adenovirus Interactions. |
| Q42321099 | MicroRNAs in HIV-1 infection: an integration of viral and cellular interaction at the genomic level |
| Q38802349 | MicroRNAs, HIV and HCV: a complex relation towards pathology. |
| Q27015778 | MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy |
| Q47600043 | Molecular Control of HIV and SIV Latency |
| Q36515063 | Molecular mechanisms of HIV latency |
| Q47555946 | Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature |
| Q28487524 | Phosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytes |
| Q89863246 | Prediction of new associations between ncRNAs and diseases exploiting multi-type hierarchical clustering |
| Q38727211 | Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV. |
| Q37346014 | RNA viruses and microRNAs: challenging discoveries for the 21st century. |
| Q38177273 | Reactivation of latent HIV: do all roads go through P-TEFb? |
| Q37005470 | Reconstructing the temporal progression of HIV-1 immune response pathways |
| Q64259746 | Regulation of cyclin T1 during HIV replication and latency establishment in human memory CD4 T cells |
| Q37631411 | Role of noncoding RNAs in the regulation of P-TEFb availability and enzymatic activity |
| Q58099445 | Roles of CDKs in RNA Polymerase II Transcription of the HIV-1 Genome |
| Q26782187 | Roles of microRNAs and long-noncoding RNAs in human immunodeficiency virus replication |
| Q37155048 | SIV replication is directly downregulated by four antiviral miRNAs. |
| Q36601909 | Short Communication: The Broad-Spectrum Histone Deacetylase Inhibitors Vorinostat and Panobinostat Activate Latent HIV in CD4(+) T Cells In Part Through Phosphorylation of the T-Loop of the CDK9 Subunit of P-TEFb. |
| Q34656952 | Short chain fatty acids potently induce latent HIV-1 in T-cells by activating P-TEFb and multiple histone modifications |
| Q39023875 | Short communication: SAHA (vorinostat) induces CDK9 Thr-186 (T-loop) phosphorylation in resting CD4+ T cells: implications for reactivation of latent HIV. |
| Q35767091 | Subversion of Cell Cycle Regulatory Mechanisms by HIV. |
| Q37285015 | Suppressed expression of miR-378 targeting gzmb in NK cells is required to control dengue virus infection |
| Q52431127 | Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies. |
| Q40135003 | The HIV-1 Tat protein: mechanism of action and target for HIV-1 cure strategies. |
| Q53175931 | The Role of miRNAs in Virus-Mediated Oncogenesis. |
| Q38096026 | The genetic basis of resistance to HIV infection and disease progression |
| Q47604571 | The role of miR-29a in HIV-1 replication and latency |
| Q26999858 | Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure |
| Q39160623 | Underlying mechanisms of HIV-1 latency. |
| Q94683922 | Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients |
| Q40129315 | Unique microRNA expression in the colonic mucosa during chronic HIV-1 infection. |
| Q36674641 | miR-132 enhances HIV-1 replication |
| Q39408487 | miR-29a associates with viro-immunological markers of HIV infection in treatment experienced patients. |
| Q36395827 | miRNA profiles of monocyte-lineage cells are consistent with complicated roles in HIV-1 restriction |
Search more.